Menu Back to 06

Track 6: Preclinical Development and Early-Phase Clinical Research

DIA 2017: Driving Insights to Action

Preclinical and early-phase clinical research provides initial dosing and safety data for new drugs. This track focuses on the latest strategies used in early-stage compound selection, updates on safety considerations for both drugs and biologics, how PK/PD affects dosing strategies, and methods to improve data quality and integrity for proper downstream decision-making.

Sessions in Preclinical Development and Early-Phase Clinical Research

Monday, June 28

Tuesday, June 29

Wednesday, June 30

Thursday, July 1

Who is This Track Designed For?

Professionals involved in: pharmacology and toxicology, nonclinical safety testing, clinical research, clinical operations, safety and pharmacovigilance, project management, patient centricity, and statistics; formulation science, pharmacokinetics/pharmacodynamics, epidemiology, toxicology, and regulatory affairs.

View Other Tracks


Registration Rates

Back to DIA 2021

Back to DIAglobal.org